-
FDA approves Medtronics’ ‘artificial pancreas’ for Type 1 diabetes
SILVER SPRING, Md. — The Food and Drug Administration this week approved a new device that can automatically monitor glucose levels and provide doses of basal insulin for patients 14 years and older with Type 1 diabetes. Medtronic’s MiniMed 670G hybrid closed loop system is often called an ‘artificial pancreas’ because of its ability to adjust insulin levels with little user input.FDA approves Janssen’s Invokamet XR
SILVER SPRING, Md. — The Food and Drug Administration has approved Janssen Pharmaceuticals’ Invokamet XR, a once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday. The drug is indicated as a first-line treatment to improve blood glucose control in adults with Type 2 diabetes alongside diet and exercise.XThis ad will auto-close in 10 seconds